Urinary #biomarker discovery provides new hope for #Parkinson’s Disease sufferers – Biotechin.Asia

Originally posted 2016-08-03 08:41:59.

Researchers from the University of Alabama at Birmingham have found that a new urinary biomarker, SER(P)-1292 LRRK2, correlates with Parkinson’s disease. Early studies indicate that this phosphorylated LRRK2 protein could potentially be used as a diagnostic/prognostic marker or a therapeutic target to treat patients with Parkinson’s disease. These preliminary findings were recently published in two separate journals, Neurology and Movement Disorders, in March and June 2016, respectively.

Esta entrada fue publicada en Sin categoría y etiquetada . Guarda el enlace permanente.

Deja un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *